Orient Pharma can provide clinical study related service to help partners and sponsors whether in Taiwan or overseas (US, EU, Japan, etc.) to conduct multi-nation, multi-center early phase (Phase I ~ Phase III) clinical studies in Taiwan, Hong Kong and Singapore according to GCP, study protocol, sponsor’s SOPs and applicable regulations.

General Activities
	Provide advices on clinical study strategies and health authorities’ requirements
	Provide consultation for planning clinical studies
	Conduct pre-study assessment and identify proper study sites
	Complete qualification process for Contract Research Organizations (CRO) and clinical study related vendors
	Conduct Clinical Project Management
	Negotiate and complete study contract process with study sites
	Negotiate and complete study contract process with study sites
	Complete Institutional Review Board (IRB) or Ethics Committee(EC)’s required process for Clinical Trial Application
	Arrange and hold investigator meetings
	Provide study monitoring services (including Site Initiation Visit, Monitoring Visit and Site Close-out Visit)
	Purchase of comparator for clinical trials
	Study specific labelling
Current Clinical Study Partners and Sponsors
	AndroScience Corporation
	CEL-SCI Corporation
	Durect Corporation
	NanoCarrier Co., Ltd.
	Orient Europharma Co., Ltd.
	Pierre Fabre Medicament
	Sansho Co., Ltd
	Kissei Pharmaceutical Co., Ltd
	Toray Industries, Inc.